Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4756 results

Sort By:

GUIDEX® Versus Launcher™ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR)

Study ID: NCT06009757
Start Date: 2024-08
End Date: 2025-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

GUIDEX® guiding catheter

Launcher™ coronary guide catheter

Sponsor

Tianjin Demax Medical Technology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Culturally Responsive Caregiver Support

Study ID: NCT04856462
Start Date: 2024-09-01
End Date: 2026-05-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Education Support

Phone Call

Sponsor

University of Michigan

Source: clinicaltrials.gov

Share:
Add to list

UltraSound Evaluation of Fluid tOleRanCE for Acute Kidney Injury

Study ID: NCT06411080
Start Date: 2024-09-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Ultrasound evaluation of fluid tolerance

Sponsor

Hospital Center of the University of Montreal (CHUM)

Source: clinicaltrials.gov

Share:
Add to list

Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism

Study ID: NCT05114980
Start Date: 2025-07
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment

Parathyroid Allotransplant

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People

Study ID: NCT05251480
Start Date: 2024-12-30
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Standard of Care

DermGEN™

Sponsor

DeCell Technologies Inc.

Source: clinicaltrials.gov

Share:
Add to list

Semi-permanent Acupuncture Effect on Cervical Ripening

Study ID: NCT06357962
Start Date: 2024-09
End Date: 2025-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Semi-permanent acupuncture

Sham of semi-permanent acupuncture

Sponsor

Health Consortium of Alt Penedès and Garraf

Source: clinicaltrials.gov

Share:
Add to list

Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia

Study ID: NCT06264362
Start Date: 2024-10-09
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Tailored Physical Activity Program

Sponsor

Drexel University

Source: clinicaltrials.gov

Share:
Add to list

Close Obstructive Sleep Apnea (OSA) Trial

Study ID: NCT06113562
Start Date: 2024-08-28
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

PFO closure

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Study ID: NCT06317662
Start Date: 2024-10-28
End Date: 2027-12-21
Study Type

Interventional

Study Phase

Phase2

No. of Participants

171

Intervention / Treatment

Asparaginase Erwinia chrysanthemi

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration

Calaspargase Pegol

Computed Tomography

Cyclophosphamide

Cytarabine

Daunorubicin

Dexamethasone

Doxorubicin

Echocardiography

FDG-Positron Emission Tomography

Leucovorin

Lumbar Puncture

Magnetic Resonance Imaging

Mercaptopurine

Methotrexate

Multigated Acquisition Scan

Pegaspargase

Prednisolone

Prednisone

Therapeutic Hydrocortisone

Thioguanine

Venetoclax

Vincristine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab in Locally Advanced Sinonasal Carcinoma

Study ID: NCT05925491
Start Date: 2024-10
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

Pembrolizumab

Cisplatin

Docetaxel

Carboplatin

Sponsor

Scientific Clinical Institutes Maugeri SpA

Source: clinicaltrials.gov

Share:
Add to list